Detailed information for compound 38581

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 638.758 | Formula: C32H46N8O6
  • H donors: 6 H acceptors: 6 LogP: 3.53 Rotable bonds: 19
    Rule of 5 violations (Lipinski): 3
  • SMILES: [N-]=[N+]=NC[C@H]([C@H]([C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)C1CCOCC1)CC1CCCCC1)O)O
  • InChi: 1S/C32H46N8O6/c33-40-36-19-28(41)29(42)25(15-21-7-3-1-4-8-21)37-32(45)27(17-24-18-34-20-35-24)39-31(44)26(16-22-9-5-2-6-10-22)38-30(43)23-11-13-46-14-12-23/h2,5-6,9-10,18,20-21,23,25-29,41-42H,1,3-4,7-8,11-17,19H2,(H,34,35)(H,37,45)(H,38,43)(H,39,44)/t25-,26+,27+,28-,29+/m1/s1
  • InChiKey: USGGZYYLFZHMLW-LLQHYSMESA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens renin Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Plasmodium falciparum plasmepsin IV Get druggable targets OG5_126885 All targets in OG5_126885
Theileria parva pepsinogen, putative Get druggable targets OG5_126885 All targets in OG5_126885
Loa Loa (eye worm) aspartic protease BmAsp-2 Get druggable targets OG5_126885 All targets in OG5_126885
Toxoplasma gondii aspartyl proteinase (eimepsin), putative Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium falciparum plasmepsin II Get druggable targets OG5_126885 All targets in OG5_126885
Neospora caninum Renin, related Get druggable targets OG5_126885 All targets in OG5_126885
Schistosoma mansoni cathepsin D (A01 family) Get druggable targets OG5_126885 All targets in OG5_126885
Schistosoma mansoni subfamily A1A unassigned peptidase (A01 family) Get druggable targets OG5_126885 All targets in OG5_126885
Echinococcus multilocularis cathepsin d (lysosomal aspartyl protease) Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium vivax plasmepsin IV, putative Get druggable targets OG5_126885 All targets in OG5_126885
Schistosoma japonicum Cathepsin D precursor, putative Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium yoelii hypothetical protein Get druggable targets OG5_126885 All targets in OG5_126885
Trichomonas vaginalis Clan AA, family A1, cathepsin D-like aspartic peptidase Get druggable targets OG5_126885 All targets in OG5_126885
Cryptosporidium hominis aspartyl protease precursor Get druggable targets OG5_126885 All targets in OG5_126885
Neospora caninum Pepsinogen A1, related Get druggable targets OG5_126885 All targets in OG5_126885
Echinococcus granulosus cathepsin d lysosomal aspartyl protease Get druggable targets OG5_126885 All targets in OG5_126885
Candida albicans vacuolar aspartic proteinase precursor similar to S. cerevisiae PEP4 (YPL154C) Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium falciparum plasmepsin VI Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium falciparum plasmepsin I Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium berghei plasmepsin VI Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium yoelii plasmepsin Get druggable targets OG5_126885 All targets in OG5_126885
Candida albicans vacuolar aspartic proteinase precursor similar to S. cerevisiae PEP4 (YPL154C) Get druggable targets OG5_126885 All targets in OG5_126885
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium knowlesi aspartyl protease, putative Get druggable targets OG5_126885 All targets in OG5_126885
Babesia bovis eukaryotic aspartyl protease family protein Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium vivax aspartyl proteinase, putative Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium yoelii hypothetical protein Get druggable targets OG5_126885 All targets in OG5_126885
Schistosoma japonicum ko:K01379 cathepsin D [EC3.4.23.5], putative Get druggable targets OG5_126885 All targets in OG5_126885
Theileria parva cathepsin E, putative Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium berghei plasmepsin IV Get druggable targets OG5_126885 All targets in OG5_126885
Toxoplasma gondii aspartyl protease ASP1 Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium knowlesi plasmepsin IV, putative Get druggable targets OG5_126885 All targets in OG5_126885
Cryptosporidium parvum membrane bound aspartyl proteinase with a signal peptide plus transmembrane domain Get druggable targets OG5_126885 All targets in OG5_126885
Schistosoma mansoni cathepsin D (A01 family) Get druggable targets OG5_126885 All targets in OG5_126885

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Plasmodium falciparum plasmepsin X renin 406 aa 352 aa 26.4 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma brucei AMP deaminase, putative 0.0213 0.0816 0.5
Trypanosoma cruzi AMP deaminase, putative 0.0213 0.0816 0.5
Mycobacterium ulcerans adenosine deaminase 0.0654 1 0.5
Leishmania major adenine aminohydrolase 0.0654 1 1
Echinococcus granulosus adenosine deaminase 0.0654 1 1
Trypanosoma cruzi AMP deaminase 2, putative 0.0213 0.0816 0.5
Trypanosoma cruzi AMP deaminase, putative 0.0213 0.0816 0.5
Trypanosoma brucei AMP deaminase, putative 0.0213 0.0816 0.5
Loa Loa (eye worm) hypothetical protein 0.0441 0.5563 0.5169
Trypanosoma cruzi adenosine monophosphate deaminase, putative 0.0213 0.0816 0.5
Plasmodium falciparum adenosine deaminase 0.0654 1 1
Onchocerca volvulus Adenosine deaminase homolog 0.0654 1 1
Schistosoma mansoni adenosine deaminase-related 0.0654 1 1
Trichomonas vaginalis adenosine deaminase, putative 0.0654 1 0.5
Loa Loa (eye worm) hypothetical protein 0.0441 0.5563 0.5169
Echinococcus multilocularis adenosine deaminase 0.0654 1 1
Trypanosoma cruzi AMP deaminase, putative 0.0213 0.0816 0.5
Toxoplasma gondii Adenosine/AMP deaminase domain-containing protein 0.0654 1 1
Plasmodium vivax adenosine deaminase, putative 0.0654 1 1
Mycobacterium tuberculosis Probable adenosine deaminase Add (adenosine aminohydrolase) 0.0654 1 0.5
Schistosoma mansoni adenosine deaminase 0.0654 1 1
Treponema pallidum adenosine deaminase 0.0654 1 0.5
Trichomonas vaginalis adenosine deaminase, putative 0.0654 1 0.5
Trypanosoma cruzi adenosine monophosphate deaminase-like protein, putative 0.0213 0.0816 0.5
Loa Loa (eye worm) hypothetical protein 0.0441 0.5563 0.5169
Trypanosoma brucei AMP deaminase, putative 0.0213 0.0816 0.5
Entamoeba histolytica adenosine deaminase, putative 0.0654 1 1
Loa Loa (eye worm) hypothetical protein 0.0441 0.5563 0.5169
Loa Loa (eye worm) hypothetical protein 0.0654 1 1
Trypanosoma brucei adenosine monophosphate deaminase, putative 0.0213 0.0816 0.5
Schistosoma mansoni AMP deaminase 0.0213 0.0816 0.0816
Mycobacterium leprae Probable adenosine deaminase Add (ADENOSINE AMINOHYDROLASE) 0.0654 1 0.5
Trypanosoma cruzi AMP deaminase, putative 0.0213 0.0816 0.5
Entamoeba histolytica adenosine deaminase, putative 0.0654 1 1
Trypanosoma cruzi AMP deaminase, putative 0.0213 0.0816 0.5
Toxoplasma gondii Adenosine/AMP deaminase domain-containing protein 0.0654 1 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 0.7 nM Inhibitory activity against purified human plasma renin at pH 6.0 ChEMBL. 2657067
IC50 (binding) = 0.7 nM Inhibitory activity against purified human plasma renin at pH 6.0 ChEMBL. 2657067
IC50 (binding) = 7.6 nM Inhibitory activity against human plasma renin at pH 7.4 ChEMBL. 2657067
IC50 (binding) = 7.6 nM Inhibitory activity against human plasma renin at pH 7.4 ChEMBL. 2657067
Solubility = 0.023 mg ml-1 Solubility of the compound in pH 6.5 buffer ChEMBL. 2657067

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.